A Phase I Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Fimasartan (Primary) ; Linagliptin (Primary)
- Indications Diabetic nephropathies; Essential hypertension; Hypertension; Kidney disorders; Myocardial infarction; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 16 Jan 2018 Status changed from recruiting to completed.
- 30 Aug 2017 Status changed from active, no longer recruiting to recruiting.
- 16 Aug 2017 New trial record